Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2023 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.
Gottschlich A, Hong Q, Gondara L, Alam MS, Cook DA, Martin RE, Lee M, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, Krajden M, Smith LW, Ogilvie GS. Gottschlich A, et al. Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):904-911. doi: 10.1158/1055-9965.EPI-23-1587. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38773687 Free PMC article.
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort.
Gottschlich A, van Niekerk D, Smith LW, Gondara L, Melnikow J, Cook DA, Lee M, Stuart G, Martin RE, Peacock S, Franco EL, Coldman A, Krajden M, Ogilvie G. Gottschlich A, et al. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):22-29. doi: 10.1158/1055-9965.EPI-20-1177. Epub 2020 Oct 20. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33082202 Free PMC article. Clinical Trial.
Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.
Gottschlich A, Gondara L, Smith LW, Cook D, Martin RE, Lee M, Peacock S, Proctor L, Stuart G, Krajden M, Franco EL, van Niekerk D, Ogilvie G. Gottschlich A, et al. Int J Cancer. 2022 Sep 15;151(6):897-905. doi: 10.1002/ijc.34039. Epub 2022 May 10. Int J Cancer. 2022. PMID: 35460070 Free PMC article. Clinical Trial.
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study.
Gottschlich A, Gondara L, Smith LW, Anderson JJ, Cook D, Krajden M, Lee M, Martin RE, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, van Niekerk D, Ogilvie GS. Gottschlich A, et al. Lancet Reg Health Am. 2023 Sep 29;26:100598. doi: 10.1016/j.lana.2023.100598. eCollection 2023 Oct. Lancet Reg Health Am. 2023. PMID: 37786399 Free PMC article.